tardyferon

the uth hour at ers s), te ld if et, k, 5, 6 - alts, ee - nel giu gastrointestinal diseases if you experience any adverse effects, talk to your doctor or pharmacist, this also applies to any adverse reaction that wou mentioned in this leaflet, you can also report the side effects directly via the national reporting system, 5, how to store tardyferon b9, film-coated tablet? no special storage precautions, keep this drug out from sight and reach of children, do not use this medicine after date of expiry as shown on outside packaging, the expiry date refers to the last day of this month, do not dispose any medication in the sewage system or with household wastes, ask your pharmacist to eliminate unused these measures are meant to protect the environment, 6, contents of packaging and other information what tardyferon b9, film-coated tablets, contains: actives substances are: iron,,,,,,,,,,, in form of dried ferrous sulfate, folic acid (dried basis),, for a film-coated tablet other components: www boulevard de l'environnement - fondouk choucha 2013-b,p, 76-ben arous tunisia headquarters: immeuble horizon rue du lac winnipeg les berges du lac 1053, tunis, tunisia last date to which this leaflet has been revised is september 2019 amm n°: boite de 30: 9323023-boite de 90: 9323026 50,0 154 0,3 maltodextrin, microcrystalline cellulose, triethyl citrate, talc, ammoniomethacrylate copolymer type b (eudragit rs 30d) ar a (eudragit rl 30d), glycerol dibehenate, coating: titanium dioxide (e171), sepilfilm lp010 (hypromellose, microcrystalline cellulose, stearic acid), yellow iron red iron oxide, triethyl citrate, what is tardyferon b9, film-coated tablet and content of the outside packaging? this drug is provided as a film-coated tablet, box of 30 or 90, manufacturer and holder of the marketing authorisation pierre fabre medicament production tunisie